Azacitidine

NDC 63323-771 · Fresenius Kabi USA, LLC

Generic nameAzacitidine

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)AZACITIDINE

Strength100 mg/30mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

63323-771-39 — 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-771-39) / 30 mL in 1 VIAL, SINGLE-DOSE

J9025 — Injection, azacitidine, 1 mg Medicare Part B payment limit (ASP + 6%): $0.40

FDA lists these products with the same active ingredient.

43598-305 — Azacitidine, 43598-465 — Azacitidine, 43598-678 — AZACITIDINE, 43817-906 — Azacitidine, 55150-393 — AZACITIDINE, 58458-002 — Azacitidine, 59572-102 — azacitidine, 59572-730 — azacitidine, 59572-740 — azacitidine, 60505-6271 — azacitidine, 68001-313 — Azacitidine, 68001-527 — Azacitidine, 68001-620 — Azacitidine, 69539-112 — Azacitidine, 70069-857 — Azacitidine, 70121-1237 — AZACITIDINE, 71288-115 — Azacitidine, 71288-153 — Azacitidine, 72485-201 — azacitidine, 72572-020 — Azacitidine, +7 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.